Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Notice: Prescription Drug List (PDL): Multiple additions March 12, 2018 Our file number: 18-102696-288 The purpose of this Notice of Amendment is to notify about the additions of avelumab, dupilumab, guselkumab, lifitegrast, lotilaner, olaratumab, sebelipase alfa, semaglutide,…
Notice: Prescription Drug List (PDL): Multiple Additions Janurary 4, 2018 Our reference number: 17-114235-356 The purpose of this Notice of Amendment is to notify about the additions of durvalumab, glycopyrrolate, letermovir, migalastat, netupitant/palonosetron hydrochloride to…
Notice - Prescription Drug List (PDL): Multiple Additions (PDF Version - 305 K) October 19, 2017 Our file number: 17-110956-588 The purpose of this Notice of Amendment is to notify about the additions of Defibrotide sodium, Glecaprevir/Pibrentasvir, Midostaurin, Ocrelizumab and…
Notice - Prescription Drug List (PDL): Hydroquinone August 29, 2017 Our file number: 17-109315-912 The purpose of this Notice of Intent to Amend is to notify that Health Canada will add certain hydroquinone products to the Prescription Drug List (PDL). Only the Human part of the…
Questions and Answers - Naloxone 1. What is naloxone? Naloxone is a drug that prevents or reverses the effects of opioids, including respiratory depression, sedation, and hypotension. It can be used in emergency situations to reduce opioid overdose (OD) deaths. 2. How is naloxone…
Notice - Prescription Drug List (PDL): Multiple additions May 19, 2017 Our file number: 17-105533-859 The purpose of this Notice of Amendment is to notify the additions of atezolizumab, eliglustat and obeticholic acid to the Human and Veterinary Prescription Drug Lists (PDL).…
Notice - Prescription Drug List (PDL): Multiple additions April 21, 2017 Our file number: 17-104599-650 The purpose of this Notice of Amendment is to notify the additions of Brexpiprazole, Necitumumab, Pegaspargase, and Vernakalant hydrochloride to the Human and Veterinary…
Notice - Prescription Drug List (PDL): Multiple additions March 29, 2017 Our file number: 17-103107-174 The purpose of this Notice of Amendment is to notify the additions of Eluxadoline, Peramivir, Propiverine hydrochloride and Sarilumab to the Human and Veterinary Prescription…
Notice: Prescription Drug List (PDL): Multiple Additions [2017-06-23] June 23, 2017 Our file number: 17-106422-736 The purpose of this Notice of Amendment is to notify the additions of Lixisenatide, Ozenoxacin and Reslizumab to the Human and Veterinary Prescription Drug Lists…
Notice of Consultation - Prescription Drug List (PDL): Veterinary and Human Antimicrobials Notice of Consultation Prescription Drug List (PDL): Veterinary and Human Antimicrobials July 5, 2017 Our file number: 17-106962-472 This Notice of Consultation provides an opportunity to…
Page 2323 sur 3977Affichage de 23221 à 23230 sur 39762
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
